PLRX
Pliant Therapeutics, Inc.Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| — | $0 | $0 | $1.58M | $9.69M | $7.57M | $41.82M | $57.05M | |
| $79.31M | $109.16M | $169.31M | $127.8M | $96.94M | $77.55M | $66.19M | $47.35M | |
| $39.91M | $47.22M | $59.06M | $57.93M | $39.95M | $27.56M | $17.27M | $10.93M | |
| $119.21M | $156.37M | $228.37M | $185.73M | $136.89M | $105.11M | $83.46M | $58.28M | |
| -$119.21M | -$156.37M | -$228.37M | -$184.15M | -$127.2M | -$97.54M | -$41.65M | -$1.23M | |
| — | — | — | -11654.75% | -1313.37% | -1288.1% | -99.59% | -2.16% | |
| $1.76M | $2.56M | $3.02M | $1.27M | $791K | $0 | — | — | |
| — | — | — | — | — | — | $478K | $816K | |
| — | — | — | — | — | — | -$366K | -$216K | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$113.22M | -$149.34M | -$210.3M | -$161.34M | -$123.32M | -$97.26M | -$41.53M | -$631K | |
| — | — | — | -10211.14% | -1273.32% | -1284.51% | -99.32% | -1.11% | |
| -$155.29M | — | — | — | -$123.32M | -$97.26M | -$41.53M | -$6.86M | |
| -$113.72M | -$149.68M | -$210.33M | -$159.03M | -$125.08M | -$97.43M | -$41.56M | -$632K | |
| USD/shares | — | -$2.43 | -$3.47 | -$2.75 | -$2.94 | -$2.71 | -$1.95 | -$4.22 |
| USD/shares | — | -$2.43 | -$3.47 | -$2.75 | -$2.94 | -$2.71 | -$1.95 | -$4.22 |
| shares | — | 61.37M | 60.54M | 58.72M | 42.02M | 35.85M | 21.34M | 1.62M |
| shares | — | 61.37M | 60.54M | 58.72M | 42.02M | 35.85M | 21.34M | 1.62M |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Reportable Segment | $0 | $0 | $1,580,000 | $9,685,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Reportable Segment | -$156,373,000 | -$228,365,000 | -$184,145,000 | -$127,200,000 |
Operating Margin by Segment (%)
| Component | 2023-12-31 | 2022-12-31 |
|---|---|---|
| Reportable Segment | -11654.7% | -1313.4% |